CES1 and SLC6A2 Genetic Variants As Predictors of Response To Methylphenidate in Autism Spectrum Disorders.
Marta H HernándezValentin BoteAlexandre Serra-LLovichMarc CendrosJuliana SalazarConcepción MestresSilvina GuijarroAida AlvarezCristina LamborenaIria MendezBernardo SanchezAmaia HervasMaría Jesús ArranzPublished in: Pharmacogenomics and personalized medicine (2022)
CES1 genetic variants may influence the clinical outcome of MPH treatment in ASD comorbid with ADHD children and adolescents.